Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: Study of 178 cases and guidelines for diagnosis

Medicine (United States)

Volumn 92, Issue 1, 2013, Pages 15-24

  Fernandez, Carla ^a   Bardin, Nathalie ^a   De Paula, André Maues ^a   Salort Campana, Emmanuelle ^b   Benyamine, Audrey ^c   Franques, Jérôme ^b   Schleinitz, Nicolas ^d   Weiller, Pierre Jean ^c   Pouget, Jean ^b   Pellissier, Jean François ^a   Figarella Branger, Dominique ^a  

^a Department of Pathology and Neuropathology ^*  (France)

^b Hô pital Necker Enfants Malades Centre de Référence des Maladies Neuromusculaires Unitéde Neuropédiatrie   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; DERMATOMYOSITIS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MYOSITIS; POLYMYOSITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; MYOSITIS; RETROSPECTIVE STUDIES;

EID: 84871925352     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31827ebba1     Document Type: Article

References (28)

1. Amato AA, Griggs RC. Unicorns, dragons, polymyositis, and othermythological beasts. Neurology. 2003;61:288-289.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of twoparts). N Engl J Med. 1975;292:344-347.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of twoparts). N Engl J Med. 1975;292:403-407.
4. Bronner IM, Hoogendijk JE, Wintzen AR, van der Meulen MF, LinssenWH, Wokke JH, de Visser M. Necrotising myopathy, an unusualpresentation of a steroid-responsive myopathy. J Neurol. 2003;250:480-485.
5. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B,Ghirardello A, Grondal G, Hietarinta M, Isenberg D, Kalden JR,Lundberg I, Moutsopoulos H, Roux-Lombard P, Vencovsky J,Wikman A, Seelig HP, van Engelen BG, van Venrooij WJ. Autoantibodyprofiles in the sera of European patients with myositis. Ann RheumDis. 2001;60:116-123. (Pubitemid 32102201)
6. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. Thediagnostic utility of myositis autoantibody testing for predicting therisk of cancer-associated myositis. Ann Rheum Dis. 2007;66:1345-1349. (Pubitemid 47492479)
7. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM,Mammen AL. A novel autoantibody recognizing 200-kd and 100-kdproteins is associated with an immune-mediated necrotizing myopathy.Arthritis Rheum. 2010;62:2757-2766.
8. Civatte M, Schleinitz N, Krammer P, Fernandez C, Guis S, Veit V,Pouget J, Harle JR, Pellissier JF, Figarella-Branger D. Class I MHCdetection as a diagnostic tool in noninformative muscle biopsies ofpatients suffering from dermatomyositis (DM). Neuropathol ApplNeurobiol. 2003;29:546-552. (Pubitemid 37548349)
9. Dalakas MC. Review: an update on inflammatory and autoimmunemyopathies. Neuropathol Appl Neurobiol. 2011;37:226-242.
10. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet.2003;362:971-982. (Pubitemid 37159295)
11. Dimitri D, Andre C, Roucoules J, Hosseini H, Humbel RL, Authier FJ.Myopathy associated with anti-signal recognition peptide antibodies:clinical heterogeneity contrasts with stereotyped histopathology. MuscleNerve. 2007;35:389-395. (Pubitemid 46364097)
12. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C,Rondinone R, Sarzi-Puttini P, Todesco S, Doria A. Clinical implicationsof autoantibody screening in patients with autoimmune myositis.Autoimmunity. 2006;39:217-221. (Pubitemid 43879034)
13. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specificautoantibodies: their clinical and pathogenic significance in diseaseexpression. Rheumatology (Oxford). 2009;48:607-612.
14. Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE,Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ,van Engelen BG. Anti-signal recognition particle autoantibodies:marker of a necrotising myopathy. Ann Rheum Dis.2006;65:1635-1638. (Pubitemid 44799678)
15. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE,Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMCinternational workshop: trial design in adult idiopathic inflammatorymyopathies, with the exception of inclusion body myositis, 10Y12 October 2003, Naarden, The Netherlands. Neuromuscul Disord.2004;14:337-345. (Pubitemid 38507409)
16. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senecal JL.Heterogeneity of autoantibodies in 100 patients with autoimmunemyositis: insights into clinical features and outcomes. Arthritis ResTher. 2007;9:R78.
17. Limaye VS, Blumbergs P, Roberts-Thomson PJ. Idiopathicinflammatory myopathies. Intern Med J. 2009;39:179-190.
18. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH,Miller FW. A new approach to the classification of idiopathicinflammatory myopathy: myositis-specific autoantibodies define usefulhomogeneous patient groups. Medicine (Baltimore). 1991;70:360-374.
19. Mammen AL. Autoimmune myopathies: autoantibodies, phenotypesand pathogenesis. Nat Rev Neurol. 2011;7:343-354.
20. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A,Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme a reductase in patients with statin-associatedautoimmune myopathy. Arthritis Rheum. 2011;63:713-721.
21. Miller FW, Rider LG, Plotz PH, Isenberg DA, Oddis CV. Diagnosticcriteria for polymyositis and dermatomyositis. Lancet.2003;362:1762-1763.
22. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodiesto the signal recognition particle: clinical and pathological features.J Neurol Neurosurg Psychiatry. 2002;73:420-428.
23. Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to thediagnosis and nosology of inflammatory muscle disease. Joint BoneSpine. 2006;73:646-654. (Pubitemid 44932242)
24. Takada T, Hirakata M, Suwa A, Kaneko Y, Kuwana M, Ishihara T,Ikeda Y. Clinical and histopathological features of myopathies inJapanese patients with anti-SRP autoantibodies. Mod Rheumatol.2009;19:156-164.
25. Targoff IN, Miller FW, Medsger TA Jr, Oddis CV. Classification criteriafor the idiopathic inflammatory myopathies. Curr Opin Rheumatol.1997;9:527-535. (Pubitemid 27504210)
26. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y,Senecal JL. Novel classification of idiopathic inflammatory myopathiesbased on overlap syndrome features and autoantibodies: analysis of100 French Canadian patients. Medicine (Baltimore).2005;84:231-249. (Pubitemid 41026298)
27. van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, vanVenrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH,de Visser M. Polymyositis: an overdiagnosed entity. Neurology.2003;61:316-321. (Pubitemid 36975958)
28. Yamanishi Y, Maeda H, Katayama S, Ishioka S, Yamakido M.Scleroderma-polymyositis overlap syndrome associated with anti-Kuantibody and rimmed vacuole formation. J Rheumatol.1996;23:1991-1994. (Pubitemid 26376130)